Rapport Therapeutics Cash Flow Statement 2022-2024 | RAPP

Fifteen years of historical annual cash flow statements for Rapport Therapeutics (RAPP).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20232022
$-34.79$-10.65
$0.04$0.02
$4.92$5.91
$4.95$5.92
$0$0
$0$0
$0.86$1.45
$-3.58$-0.11
$2.65$1.49
$-27.18$-3.24
$-1.64$-0.28
$0$-5.00
$0$0
$-77.22$0
$0$0
$-77.22$0
$0$0
$-78.86$-5.28
$0$8.00
$0$0
$0$8.00
$0.05$0.03
$145$31.79
$0$0
$-0.13$-0.10
$145$39.69
$39.10$31.16
$3.53$0.56
$0$0